PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsmajor depressive disorder
MeSH D003865 - major depressive disorder
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D003866:Depressive disorder
164 Companies
36 Drugs
$
Success rate
D003865: 
Major depressive disorder
79 Companies
13 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AbbVieLevomilnacipran Fetzima 2026-01-11 2013-07-25   
Escitalopram oxalate Lexapro  2002-08-14   
Milnacipran Savella 2023-01-14 2009-01-14   
Vilazodone Viibryd  2011-01-21   
Accord HealthcareEscitalopram oxalate Escitalopram Oxalate  2012-09-11   
Fluoxetine Fluoxetine  2020-08-27   
Lurasidone Lurasidone  2019-01-03   
Quetiapine Quetiapine  2016-11-01   
Vilazodone Vilazodone  2021-04-27   
ACRAFLurasidone Latuda  2014-03-21   
Ajanta PharmaDuloxetine Duloxetine  2017-01-06   
Brexpiprazole Brexpiprazole  2023-02-03   
Alembic PharmaceuticalsDesvenlafaxine Desvenlafaxine  2015-06-29   
Duloxetine Duloxetine  2014-06-09   
Fluoxetine Fluoxetine  2009-03-19   
Lurasidone Lurasidone  2021-05-13   
Quetiapine Quetiapine  2014-10-28   
Vilazodone Vilazodone  2020-01-10   
Alkem LaboratoriesDuloxetine Duloxetine  2015-08-26   
Quetiapine Quetiapine  2013-02-12   
Lurasidone Lurasidone  2022-12-13   
Brexpiprazole Brexpiprazole  2023-11-28   
AllerganFluoxetine Sarafem  2006-05-19   
Desvenlafaxine Desvenlafaxine  2016-07-29   
Duloxetine Duloxetine  2013-12-17   
Fluoxetine Fluoxetine  2002-01-29   
Lurasidone Lurasidone  2021-02-02   
Quetiapine Quetiapine  2013-02-27   
Amneal PharmaceuticalsEscitalopram oxalate Escitalopram Oxalate  2012-03-14   
Levomilnacipran Levomilnacipran  2019-02-04   
Lurasidone Lurasidone  2019-01-03   
Milnacipran Milnacipran  2016-04-22   
Quetiapine Quetiapine  2018-10-26   
Brexpiprazole Brexpiprazole  2023-01-31   
ANDA RepositoryBrexpiprazole Brexpiprazole  2023-10-25   
ANI PharmaceuticalsFluoxetine Fluoxetine  2008-05-20   
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
72%
65/90
Phase 2
60%
76/127
Phase 3
56%
54/96
Approved: 14Overall Success rate: 24%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AbbVie
Escitalopram oxalate,
Levomilnacipran,
Milnacipran,
Adt
Allergan
Fluoxetine,
Rapastinel,
Sodium chloride,
APIMOSTINEL,
Nmda,
Ssri,
Azzalure,
MD05
AstraZeneca
Quetiapine,
Benzodiazepine,
Escitalopram,
Dexmecamylamine,
Glutamic acid,
Sodium chloride,
LANICEMINE,
D-glutamate,
AZD7268,
Gladem,
Azd2327,
Lexapro,
AZD2066,
Wellbutrin,
Nmda,
Ssri,
Evidence,
Zyban
1
2
3
4
5
6
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use